Rosario, Monique Claire .
HRN: 23-65-46 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/05/2023
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
09/05/2023
09/12/2023
IV
430mg
Q6
CHD VSD PDA; T/c Aortic Arch Anomaly
Waiting Final Action
Indication: Empiric Type of Infection: Cardiovascular Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes